Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice

Biologicals

Volumn 32, Issue 3, 2004, Pages 157-163

  Pombo, María ^a,b   Berthold, Inge ^a   Gingrich, Elise ^a   Jaramillo, María ^a,c   Leef, Mary ^a   Sirota, Lev ^a   Hsu, Henry ^a   Arciniega, Juan ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Instituto Nacional de Higiene Rafael Rangel   (Venezuela)

^c Mexico   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; ANTIGEN; PROTECTIVE ANTIGEN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANTHRAX; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; MOUSE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; VALIDATION PROCESS;

ANIMALS; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED BALB C; SENSITIVITY AND SPECIFICITY;

ANIMALIA; ANTHRAX; BACILLUS ANTHRACIS; CAVIA;

EID: 7944220094     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2004.03.002     Document Type: Article

References (13)

1. 21 CFR Part 620.20. Food and drug administration, HHS. Code of Federal Regulation. Subpart C - anthrax vaccine adsorbed [chapter I]; 4-1-92. p. 71-2.
2. A.M. Friedlander, P.R. Pittman, and G.W. Parker Anthrax vaccine. Evidence for safety and efficacy against inhalational anthrax JAMA 282 1999 2104 2106
3. L. Baillie The development of new vaccines against Bacillus anthracis J Appl Environ Microbiol 91 2001 609 613
4. C. Petosa, R.J. Collier, K.R. Klimpel, S.H. Leppla, and R.C. Liddington Crystal structure of the anthrax toxin protective antigen Nature 385 1997 833 838
5. J.C. Milne, D. Furlong, P.C. Hanna, J.S. Wall, and R.J. Collier Anthrax protective antigen forms oligomers during intoxication of mammalian cells J Biol Chem 269 1994 20607 20612
6. W.M.S. Russell, and R.L. Burch The principles of humane experimental technique 1959 Methuen London, UK
7. ICH. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Text on validation of analytical procedures; 1994. p. 1-5.
8. The United States Pharmacopeia. USP 26. General information 〈1225〉,validation of compendial methods; 2003. p. 2439-42.
9. U.S. Food and Drug Administration. Guidance for industry: manufacturing, processing, or holding active pharmaceutical ingredients; March 1998.
10. U.S. Food and Drug Administration. Guidelines on general principles of process validation; May 1987.
11. ICH. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Validation of analytical procedures: methodology; 1996. p. 1-8.
12. S.H. Leppla Production and purification of anthrax toxin A. Johnson J.D. Corbin Methods in enzymology 165 1991 103 116
13. F. Lynn, G.F. Read, and B.D. Meade Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens Clin Diagn Lab Immunol 3 1996 689 700